The novel treatment of the medication represents a significant breakthrough in the care of the condition. Unlike existing therapies, tirzepatide impacts dual pathways – the GLP-1 hormone and GIP – resulting in https://tirzepatidepeptide587910.bloginder.com/42638479/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment